These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 28237171
1. Atypical transient subretinal exudation following photodynamic therapy for chronic central serous retinopathy: a case report. Al-Awadi A, Mandelcorn ED, Somani S. Can J Ophthalmol; 2017 Feb; 52(1):e38-e41. PubMed ID: 28237171 [No Abstract] [Full Text] [Related]
2. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment. Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913 [Abstract] [Full Text] [Related]
3. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Shinojima A, Kawamura A, Mori R, Fujita K, Yuzawa M. Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105 [Abstract] [Full Text] [Related]
4. CLINICAL FEATURES OF FLAT IRREGULAR PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Guo J, Tang W, Liu W, Chang Q, Xu G. Retina; 2021 Jan 01; 41(1):199-207. PubMed ID: 32251241 [Abstract] [Full Text] [Related]
5. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors. Hwang S, Kang SW, Kim SJ, Jang JW, Kim KT. Retina; 2019 Jun 01; 39(6):1117-1124. PubMed ID: 29517581 [Abstract] [Full Text] [Related]
6. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes. Matušková V, Vysloužilová D, Uher M. Semin Ophthalmol; 2018 Jun 01; 33(5):690-699. PubMed ID: 29252091 [Abstract] [Full Text] [Related]
7. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy. Arif F, Pryds A, Larsen M. Acta Ophthalmol; 2018 Dec 01; 96(8):821-827. PubMed ID: 30246489 [Abstract] [Full Text] [Related]
8. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea. van Dijk EHC, Dijkman G, Boon CJF. Graefes Arch Clin Exp Ophthalmol; 2017 Oct 01; 255(10):2029-2035. PubMed ID: 28674835 [Abstract] [Full Text] [Related]
9. Optical Coherence Tomography Angiography Findings in Chronic Central Serous Chorioretinopathy After Photodynamic Therapy. Tang PH, Shields R, Silva RA. Ophthalmic Surg Lasers Imaging Retina; 2019 Jan 01; 50(1):25-32. PubMed ID: 30640392 [Abstract] [Full Text] [Related]
10. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy. Yasui A, Yamamoto M, Hirayama K, Shiraki K, Theisen-Kunde D, Brinkmann R, Miura Y, Kohno T. Graefes Arch Clin Exp Ophthalmol; 2017 Feb 01; 255(2):243-254. PubMed ID: 27497611 [Abstract] [Full Text] [Related]
11. Photodynamic therapy for chronic pigment epithelial detachment in central serous chorioretinopathy. Chang MA, Bressler SB. Can J Ophthalmol; 2009 Apr 01; 44(2):221-2. PubMed ID: 19491970 [No Abstract] [Full Text] [Related]
12. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy. van Rijssen TJ, van Dijk EHC, Dijkman G, Boon CJF. Graefes Arch Clin Exp Ophthalmol; 2018 Aug 01; 256(8):1395-1402. PubMed ID: 29732468 [Abstract] [Full Text] [Related]
13. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy. Kim SW, Oh J, Oh IK, Huh K. Ophthalmic Surg Lasers Imaging; 2009 Aug 01; 40(3):300-3. PubMed ID: 19485297 [Abstract] [Full Text] [Related]
14. Microrip of Retinal Pigment Epithelium in Central Serous Chorioretinopathy. Ranjan R, Agarwal M, Verma N. JAMA Ophthalmol; 2020 Jun 01; 138(6):e193120. PubMed ID: 32525538 [No Abstract] [Full Text] [Related]
15. Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation. Yang HS, Park SH. Can J Ophthalmol; 2013 Jun 01; 48(3):e42-3. PubMed ID: 23769790 [No Abstract] [Full Text] [Related]
16. Photodynamic therapy for variant central serous chorioretinopathy: efficacy and side effects. Gupta B, Mohamed MD. Ophthalmologica; 2011 Jun 01; 225(4):207-10. PubMed ID: 21325872 [Abstract] [Full Text] [Related]
17. Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy. Cidad P, González E, Asencio M, García J. Korean J Ophthalmol; 2015 Oct 01; 29(5):331-5. PubMed ID: 26457039 [Abstract] [Full Text] [Related]
18. Modified Photodynamic Therapy Treatment of Central Serous Chorioretinopathy. Putnam CM, Vang SS. Optom Vis Sci; 2016 Jul 01; 93(7):760-71. PubMed ID: 27058592 [Abstract] [Full Text] [Related]
19. ACUTE EXACERBATION OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AT THE SITE OF A RETINAL PIGMENT EPITHELIUM APERTURE. Abramowicz S, Pasteels B, Postelmans L. Retin Cases Brief Rep; 2024 Mar 01; 18(2):206-210. PubMed ID: 36007174 [Abstract] [Full Text] [Related]
20. Relapsing Pigment Epithelial Detachment in Central Serous Chorioretinopathy After Dilated Eye Examination. German O, Jampol LM. JAMA Ophthalmol; 2020 Oct 01; 138(10):1106-1107. PubMed ID: 32880606 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]